171 results on '"Nanishi, Etsuro"'
Search Results
2. Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice
3. Reduced SARS-CoV-2 mRNA vaccine immunogenicity and protection in mice with diet-induced obesity and insulin resistance
4. mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
5. Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination
6. Adjuvantation of a SARS-CoV-2 mRNA vaccine with controlled tissue-specific expression of an mRNA encoding IL-12p70.
7. Delayed Development of Coronary Artery Aneurysm in Patients with Kawasaki Disease Who Were Clinically Responsive to Immunoglobulin
8. The immunoregulatory function of peripheral blood CD71+ erythroid cells in systemic-onset juvenile idiopathic arthritis
9. Effective infliximab therapy for the early regression of coronary artery aneurysm in Kawasaki disease
10. Precision Vaccinology Approaches for the Development of Adjuvanted Vaccines Targeted to Distinct Vulnerable Populations
11. Toward precision adjuvants: optimizing science and safety
12. The mRNA vaccine BNT162b2 demonstrates impaired TH1 immunogenicity in human elders in vitro and aged mice in vivo
13. Reduced SARS-CoV-2 mRNA vaccine immunogenicity and protection in mice with diet-induced obesity and insulin resistance
14. Memory B-Cell Pools Predict the Immune Response to Pneumococcal Conjugate Vaccine in Immunocompromised Children
15. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: Difference of the diagnostic performance between acute pneumonia and bronchitis
16. Shaping Neonatal Immunization by Tuning the Delivery of Synergistic Adjuvants via Nanocarriers
17. Adjuvant Discovery via a High Throughput Screen using Human Primary Mononuclear Cells
18. Shaping neonatal immunization by tuning delivery of synergistic adjuvants via nanocarriers
19. Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination
20. mRNA booster vaccination protects extremely aged mice against the SARS-CoV-2 Omicron variant
21. Precision Vaccine Adjuvants for Older Adults: A Scoping Review
22. Precision Vaccines: Lessons Learned From the Coronavirus Pandemic
23. Waning effectiveness of SARS-CoV-2 mRNA vaccines in older adults: a rapid review
24. Precision Vaccine Development: Cues From Natural Immunity
25. An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity
26. An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice
27. An adjuvanted SARS-CoV-2 RBD nanoparticle elicits neutralizing antibodies and fully protective immunity in aged mice
28. Bell's palsy and SARS-CoV-2 vaccines—an unfolding story – Authors' reply
29. Neonatal hemophagocytic lymphohistiocytosis associated with a vertical transmission of coxsackievirus B1
30. Detailed analysis of Japanese patients with adenosine deaminase 2 deficiency reveals characteristic elevation of type II interferon signature and STAT1 hyperactivation
31. Overlapping Features in Kawasaki Disease-Related Arthritis and Systemic-Onset Juvenile Idiopathic Arthritis: A Nationwide Study in Japan
32. Clinical and genetic investigation of 17 Japanese patients with hyperekplexia
33. Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunity
34. An adjuvant strategy enabled by modulation of the physical properties of fungal mannans elicits pan-coronavirus reactive anti-SARS-CoV-2 Spike antibodies
35. Development of Kawasaki disease in a patient with PFAPA
36. Previous antibiotic use and the development of Kawasaki disease: a matched pair case‐control study
37. Clinical Utility of Highly Purified 10% Liquid Intravenous Immunoglobulin in Kawasaki Disease
38. Procalcitonin levels predicting the infliximab response of immunoglobulin resistant Kawasaki disease
39. A Nationwide Survey of Pediatric-onset Japanese Encephalitis in Japan
40. The uselessness of procalcitonin in the diagnosis of focal bacterial central nervous system infection
41. Drug reaction with eosinophilia and systemic symptoms during primary Epstein–Barr virus infection
42. Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open‐Label, Randomized Control Study
43. Intramuscular Venous Malformation in an Infant Masquerading as Recurrent Gonarthritis
44. Polymyxin-B immobilized column-direct hemoperfusion for adolescent toxic shock syndrome
45. A nationwide survey of common viral infections in childhood among patients with primary immunodeficiency diseases
46. Nationwide Survey of Pediatric-onset Japanese Encephalitis in Japan.
47. Activation of Nod1 Signaling Induces Fetal Growth Restriction and Death through Fetal and Maternal Vasculopathy
48. Memory B-Cell Pools Predict the Immune Response to Pneumococcal Conjugate Vaccine in Immunocompromised Children
49. Clinical and genetic investigation of 17 Japanese patients with hyperekplexia
50. Staphylococcal endocarditis as the first manifestation of heritable protein S deficiency in childhood
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.